May 1 Drugmaker Merck & Co posted a 52.5 percent fall in first-quarter profit on Tuesday, hurt by hefty charge related to its collaboration with Eisai Co Ltd.
The stock chart on Merck & Co., Inc. (NYSE:MRK) hasn’t been healthy. During the past year, the shares have lost about 13% of their value. And yes, there are certainly legitimate reasons for the weakness with Merck stock. The company …
Alethea Capital Management Llc decreased Merck & Co Inc (MRK) stake by 50% reported in 2017Q3 SEC filing. …
Last week, U.S. Senator Tina Smith expressed concerns that big pharma companies plan to use their large corporate tax savings to reward shareholders instead of bringing down costs of expensive drugs and benefiting consumers. The …